Intracellular iron accumulation is significantly facilitated by diminished expression of ferroportin (FPN), the sole confirmed iron exporter ( - ) constitutes the initial ferroptotic signal
Why glutathione IV therapy over food or oral glutathione supplements

Deborah Levine: Nothing to disclose E-Posters - RECOVERY, REHABILITATION AND OUTCOME 03.00 - RECOVERY, REHABILITATION AND OUTCOME - 03.03 - PROGNOSIS AND OUTCOME AFTER STROKE P2225 - ESOC25-874 USE OF ANTIDEPRESSANTS IN YOUNG STROKE PATIENTS: INSIGHTS FROM A MULTICENTER STUDY Jenna Broman 1 , Daniela Pinter 2 , Simon Fandler-Hfler, Bettina von Sarnowski 3 , Mohamed Elmegiri 4 , Thomas Gattringer 5,6 , Robert Malinowski 3 , Juha Martola 4 , Stefan Ropele, Ulf Schminke 3 , Turgut Tatlisumak 1,7 , Christian Enzinger, Karoliina Aarnio 1 , Jukka Putaala 1 1 Department of Neurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland, 2 Department of Neurology, Research Unit for Neuronal Plasticity and Repair, Medical University of Graz, Graz, Austria, 3 Department of Neurology, University Medicine Greifswald, Greifswald, Germany, 4 Department of Radiology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland, 5 Department of Neurology, Medical University of Graz, Graz, Austria, 6 Division of Neuroradiology, Vascular and Interventional Radiology, Department of Radiology, Medical University of Graz, Graz, Austria, 7 Department of Clinical Neuroscience, Institute of Neurosciences and Physiology, Sahlgrenska Academy at University of Gothenburg & Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden Background and Aims: Depression after stroke is common and occurs in approximately one-third of patients, potentially affecting their quality of life and worsening the outcome

Anyone who exercises can benefit from carnitine supplementation because it can help reduce the accumulation of lactic acid, which is responsible for the burn felt inside the muscles during strenuous exercise
Sterile Bacteriostatic Water is a laboratory-use liquid preparation containing 0.9% benzyl alcohol as a preservative component
ROS-generating, pH-responsive and highly tunable reduced graphene oxide-embedded microbeads showing intrinsic anticancer properties and multi-drug co-delivery capacity for combination cancer therapy